X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES LUPIN LTD JUBILANT LIFE SCIENCES/
LUPIN LTD
 
P/E (TTM) x 20.1 17.0 118.4% View Chart
P/BV x 4.3 4.0 108.1% View Chart
Dividend Yield % 0.4 0.8 54.6%  

Financials

 JUBILANT LIFE SCIENCES   LUPIN LTD
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
LUPIN LTD
Mar-16
JUBILANT LIFE SCIENCES/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1872,127 8.8%   
Low Rs651,294 5.0%   
Sales per share (Unadj.) Rs364.3304.1 119.8%  
Earnings per share (Unadj.) Rs6.850.4 13.6%  
Cash flow per share (Unadj.) Rs24.560.7 40.4%  
Dividends per share (Unadj.) Rs3.007.50 40.0%  
Dividend yield (eoy) %2.40.4 543.2%  
Book value per share (Unadj.) Rs164.9243.8 67.6%  
Shares outstanding (eoy) m159.28450.58 35.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.35.6 6.1%   
Avg P/E ratio x18.433.9 54.2%  
P/CF ratio (eoy) x5.128.2 18.2%  
Price / Book Value ratio x0.87.0 10.9%  
Dividend payout %43.814.9 294.5%   
Avg Mkt Cap Rs m20,061770,740 2.6%   
No. of employees `0006.216.4 37.8%   
Total wages/salary Rs m11,05221,077 52.4%   
Avg. sales/employee Rs Th9,383.08,379.6 112.0%   
Avg. wages/employee Rs Th1,786.91,289.0 138.6%   
Avg. net profit/employee Rs Th176.31,388.7 12.7%   
INCOME DATA
Net Sales Rs m58,034137,016 42.4%  
Other income Rs m1911,877 10.2%   
Total revenues Rs m58,224138,893 41.9%   
Gross profit Rs m5,78637,535 15.4%  
Depreciation Rs m2,8124,635 60.7%   
Interest Rs m3,237446 725.5%   
Profit before tax Rs m-7234,330 -0.2%   
Minority Interest Rs m-286-88 326.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m69611,536 6.0%   
Profit after tax Rs m1,09022,707 4.8%  
Gross profit margin %10.027.4 36.4%  
Effective tax rate %-965.933.6 -2,874.4%   
Net profit margin %1.916.6 11.3%  
BALANCE SHEET DATA
Current assets Rs m29,28097,790 29.9%   
Current liabilities Rs m38,91253,872 72.2%   
Net working cap to sales %-16.632.1 -51.8%  
Current ratio x0.81.8 41.5%  
Inventory Days Days8485 99.6%  
Debtors Days Days51121 41.8%  
Net fixed assets Rs m55,71286,379 64.5%   
Share capital Rs m155901 17.1%   
"Free" reserves Rs m20,968105,735 19.8%   
Net worth Rs m26,265109,844 23.9%   
Long term debt Rs m17,16953,739 31.9%   
Total assets Rs m88,606224,378 39.5%  
Interest coverage x1.077.9 1.3%   
Debt to equity ratio x0.70.5 133.6%  
Sales to assets ratio x0.70.6 107.3%   
Return on assets %4.910.3 47.3%  
Return on equity %4.220.7 20.1%  
Return on capital %11.621.2 54.5%  
Exports to sales %37.849.1 77.0%   
Imports to sales %16.57.4 221.5%   
Exports (fob) Rs m21,93367,244 32.6%   
Imports (cif) Rs m9,56710,199 93.8%   
Fx inflow Rs m22,00471,405 30.8%   
Fx outflow Rs m11,74917,807 66.0%   
Net fx Rs m10,25553,598 19.1%   
CASH FLOW
From Operations Rs m8,026-3,690 -217.5%  
From Investments Rs m-1,744-69,434 2.5%  
From Financial Activity Rs m-4,44758,126 -7.7%  
Net Cashflow Rs m1,834-14,998 -12.2%  

Share Holding

Indian Promoters % 45.6 46.6 97.9%  
Foreign collaborators % 3.5 0.2 1,750.0%  
Indian inst/Mut Fund % 8.7 11.3 77.0%  
FIIs % 21.2 31.9 66.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 10.1 208.9%  
Shareholders   23,815 98,259 24.2%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; Auto Sector Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the auto sector and banking sector witnessing maximum selling pressure.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Lupin: Niche products boost business growth (Quarterly Results Update - Detailed)

Jun 15, 2016

Lupin has announced its 4QFY16 results. Net sales have grown by 38.6% YoY, while net profits declined by 54.8% YoY. Here is our analysis of the results.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 17, 2017 12:02 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - ALEMBIC LTD COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS